C. Danel

发表

CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial

Roger Salamon, Xavier Anglaret, R. Salamon, 2006, The Lancet.

Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008

S. Eholie, A. Minga, E. Messou, 2013, BMC Infectious Diseases.

Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa

R. Salamon, E. Bissagnéné, S. Eholie, 2007, AIDS.

Quantiferon-TB Gold: Performance for Ruling out Active Tuberculosis in HIV-Infected Adults with High CD4 Count in Côte d'Ivoire, West Africa

J. Herrmann, S. Eholie, X. Anglaret, 2014, PloS one.

Clinical Impact and Cost-Effectiveness of Making Third-Line Antiretroviral Therapy Available in Sub-Saharan Africa: A Model-Based Analysis in Côte d'Ivoire

R. Walensky, K. Freedberg, Y. Yazdanpanah, 2014, Journal of acquired immune deficiency syndromes.

Could Early Antiretroviral Therapy Entail More Risks than Benefits in Sub-Saharan African HIV-Infected Adults? A Model-Based Analysis

R. Walensky, K. Freedberg, E. Losina, 2013, Antiviral therapy.

Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age

R. Walensky, K. Freedberg, S. Eholie, 2012, AIDS.

Medium-Term Survival, Morbidity and Immunovirological Evolution in HIV-Infected Adults Receiving Antiretroviral Therapy, Abidjan, Côte D'Ivoire

R. Salamon, E. Messou, C. Seyler, 2002, Antiviral therapy.

Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies.

R. Walensky, K. Freedberg, E. Losina, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Missed opportunities for HIV testing among newly diagnosed HIV-infected adults in Abidjan, Côte d'Ivoire

S. Eholie, A. Minga, X. Anglaret, 2017, PloS one.

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

R. Salamon, H. Ahiboh, C. Rouzioux, 2015, The New England journal of medicine.

A 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in Guinea

J. Gala, D. Malvy, X. Anglaret, 2016, PLoS neglected tropical diseases.

Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV‐hepatitis B virus coinfected patients from Sub‐Saharan Africa

C. Delaugerre, F. Zoulim, S. Eholie, 2016, Journal of gastroenterology and hepatology.

Incidence and determinants of mortality and morbidity following early ART initiation in HIV-infected adults in West Africa Accepted for publication in AIDS

R. Salamon, E. Bissagnéné, S. Eholie, 2017 .

Plasma sVCAM‐1, antiretroviral therapy and mortality in HIV‐1‐infected West African adults

S. Eholie, X. Anglaret, C. Danel, 2022, HIV medicine.

Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts

G. Peytavin, S. Eholie, X. Anglaret, 2013, Journal of the International AIDS Society.

Tolerance and Acceptability of an Efavirenz-Based Regimen in 740 Adults (Predominantly Women) in West Africa

S. Eholie, X. Anglaret, C. Danel, 2006, Journal of acquired immune deficiency syndromes.

Haematological Changes in Adults Receiving a Zidovudine-Containing Haart Regimen in Combination with Cotrimoxazole in Côte D'ivoire

R. Salamon, E. Bissagnéné, A. Minga, 2005, Antiviral therapy.

Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients.

S. Eholie, E. Messou, C. Seyler, 2012, World journal of hepatology.

Association Between Medication Possession Ratio, Virologic Failure and Drug Resistance in HIV-1–Infected Adults on Antiretroviral Therapy in Côte d'Ivoire

K. Freedberg, E. Losina, C. Rouzioux, 2011, Journal of acquired immune deficiency syndromes.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Increasing Rate of TAMs and Etravirine Resistance in HIV-1–Infected Adults Between 12 and 24 Months of Treatment: The VOLTART Cohort Study in Côte d’Ivoire, West Africa

C. Rouzioux, S. Eholie, A. Minga, 2013, Journal of acquired immune deficiency syndromes.

0.1. Association of plasma sVCAM-1 and sCD14 with mortality in HIV-1 infected West African adults with high CD4 counts.

C. Rouzioux, S. Eholie, C. Dunyach-Rémy, 2020, Journal of acquired immune deficiency syndromes.

Effect of hepatitis B virus (HBV) surface‐gene variability on markers of replication during treated human immunodeficiency virus‐HBV infection in Western Africa

C. Delaugerre, F. Zoulim, S. Eholie, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Effect of hepatitis B virus (HBV) S-gene variability on markers of replication during treated HIV-HBV infection in Western Africa

F. Zoulim, S. Eholie, X. Anglaret, 2019 .

Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co‐infected patients from Western Africa

C. Delaugerre, F. Zoulim, X. Anglaret, 2018, Journal of viral hepatitis.

Short communication: Severe symptomatic hyperlactatemia among HIV type 1-infected adults on antiretroviral therapy in Côte d'Ivoire.

R. Salamon, S. Eholie, A. Minga, 2010, AIDS research and human retroviruses.

Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d’Ivoire

M. Hoelscher, S. Eholie, X. Anglaret, 2017, AIDS.

Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults

S. Eholie, X. Anglaret, C. Danel, 2022, BMC Infectious Diseases.

Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts

C. Rouzioux, S. Eholie, X. Anglaret, 2020, EBioMedicine.

Hepatitis B virus activity in untreated hepatitis B e antigen-negative human immunodeficiency virus-hepatitis B virus co-infected patients from sub-Saharan Africa.

C. Delaugerre, F. Zoulim, S. Eholie, 2019, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Occult HBV infection in untreated HIV-infected adults in Côte d'Ivoire

S. Eholie, E. Messou, C. Seyler, 2010, Antiviral therapy.

High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial

D. Ekouevi, S. Eholie, X. Anglaret, 2016, AIDS Research and Therapy.

Variation of CD4 count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings.

F. Dabis, D. Ekouevi, X. Anglaret, 2007, AIDS research and human retroviruses.

Preferences and access to community-based HIV testing sites among men who have sex with men (MSM) in Côte d’Ivoire

C. Danel, M. Inghels, L. Sika, 2022, BMJ Open.

Low Risk of Lamivudine-Resistant HBV and Hepatic Fares in Treated HIV–HBV-Coinfected Patients from Côte d'Ivoire

C. Delaugerre, F. Zoulim, S. Eholie, 2015, Antiviral therapy.

Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults.

R. Salamon, C. Rouzioux, E. Bissagnéné, 2009, The Journal of infectious diseases.

Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.

R. Salamon, C. Rouzioux, S. Eholie, 2017, The Lancet. Global health.

Twenty-Year Evolution of Hepatitis B Virus and Human Immunodeficiency Virus Prevalence and Incidence in Voluntary Blood Donors in Côte d’Ivoire

S. Eholie, A. Minga, X. Anglaret, 2018, Open forum infectious diseases.

Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting

Xavier Anglaret, F. Dabis, C. Rouzioux, 2005, Journal of Clinical Microbiology.

Mortality in relation to hepatitis B virus (HBV) infection status among HIV-HBV coinfected patients in sub-Saharan Africa after immediate initiation of antiretroviral therapy Running head: HBV profiles and mortality in HIV

C. Delaugerre, S. Eholie, X. Anglaret, 2021 .

Mortality in relation to hepatitis B virus (HBV) infection status among HIV‐HBV co‐infected patients in sub‐Saharan Africa after immediate initiation of antiretroviral therapy

E. Hyle, C. Delaugerre, S. Eholie, 2020, Journal of viral hepatitis.

Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)–Coinfected Patients With High HBV Replication

F. Zoulim, S. Eholie, X. Anglaret, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4+ cell counts

F. Zoulim, S. Eholie, X. Anglaret, 2021, Antiviral therapy.

Depressive Symptoms and Exposure to Efavirenz in West African HIV-Infected Adults

M. Carrieri, C. Protopopescu, B. Spire, 2008, HIV clinical trials.

Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus-Hepatitis B Virus Co-infected Patients from Sub-Saharan Africa.

F. Zoulim, S. Eholie, X. Anglaret, 2017, The American journal of tropical medicine and hygiene.

Lack of indinavir-associated nephrological complications in HIV-infected adults (predominantly women) with high indinavir plasma concentration in Abidjan, Côte d'Ivoire.

R. Salamon, G. Peytavin, E. Bissagnéné, 2007, AIDS research and human retroviruses.

Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question

S. Eholie, X. Anglaret, C. Danel, 2016, AIDS Research and Therapy.

High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial

D. Ekouevi, S. Eholie, X. Anglaret, 2016, AIDS Research and Therapy.

Stability of ritonavir soft capsule formulation in patients with and without a refrigerator at home in Côte d'Ivoire

G. Peytavin, X. Anglaret, C. Danel, 2006, International journal of STD & AIDS.

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

P. Maes, S. Günther, Y. Yazdanpanah, 2016, PLoS medicine.

Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

P. Maes, S. Ombelet, M. Bentahir, 2016, PLoS medicine.

Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

P. Maes, S. Günther, Y. Yazdanpanah, 2016, PLoS medicine.

Development of a Prediction Model for Ebola Virus Disease: A Retrospective Study in Nzérékoré Ebola Treatment Center, Guinea.

Y. Yazdanpanah, K. Porten, R. Kojan, 2016, The American journal of tropical medicine and hygiene.

Effect of Early Antiretroviral Therapy on Sexual Behaviors and HIV-1 Transmission Risk Among Adults With Diverse Heterosexual Partnership Statuses in Côte d'Ivoire

F. Lert, S. Eholie, X. Anglaret, 2013, The Journal of infectious diseases.

CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: Projecting beyond clinical trials

R. Walensky, K. Freedberg, Y. Yazdanpanah, 2010, Antiviral therapy.

Impact of Drug Stock-Outs on Death and Retention to Care among HIV-Infected Patients on Combination Antiretroviral Therapy in Abidjan, Côte d'Ivoire

K. Freedberg, Y. Yazdanpanah, E. Losina, 2010, PloS one.

Cascade of Provider-Initiated Human Immunodeficiency Virus Testing and Counselling at Specific Life Events (Pregnancy, Sexually Transmitted Infections, Marriage) in Côte d'Ivoire.

C. Danel, M. Inghels, A. D. du Loû, 2020 .

Cascade of Provider-Initiated HIV Testing and Counselling at Specific Life Events (Pregnancy, STIs, Marriage) in Côte d'Ivoire.

C. Danel, M. Inghels, A. Desgrées du Loû, 2020, Sexually transmitted diseases.

Variation of CD 4 Count and Percentage during Pregnancy and after Delivery : Implications for HAART Initiation in Resource-Limited Settings

F. Dabis, D. Ekouevi, X. Anglaret, 2017 .

Variation of CD 4 count and percentage among women receiving antiretroviral prophylaxis for the prevention of mother-to-child transmission of HIV : Implication for HAART initiation in resource-limited settings

F. Dabis, D. Ekouevi, X. Anglaret, 2017 .

Variation of CD4 count and percentage among women receiving antiretroviral prophylaxis for the prevention of mother-to-child transmission of HIV: Implication for HAART initiation in resource-limited settings.

F. Dabis, D. Ekouevi, V. Leroy, 2007 .

Pregnancy Outcomes in Women Exposed to Efavirenz and Nevirapine: An Appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d'Ivoire

F. Dabis, D. Ekouevi, S. Eholie, 2011, Journal of acquired immune deficiency syndromes.

Prevalence of pulmonary tuberculosis among prison inmates: A cross-sectional survey at the Correctional and Detention Facility of Abidjan, Côte d'Ivoire

D. Malvy, S. Eholie, X. Anglaret, 2017, PloS one.

Implementing preexposure prophylaxis among key populations: an opportunity for patient-centered services and management of hepatitis B

S. Eholie, C. Danel, M. Plazy, 2018, AIDS.

Sexual health needs of female sex workers in Côte d’Ivoire: a mixed-methods study to prepare the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention

S. Eholie, C. Danel, M. Plazy, 2020, BMJ Open.

Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in Côte d'Ivoire

F. Lert, S. Eholie, X. Anglaret, 2014, Journal of the International AIDS Society.

High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d’Ivoire

Xavier Anglaret, S. Eholie, X. Anglaret, 2017, PloS one.

Practices and Obstacles to Provider-Initiated HIV Testing and Counseling (PITC) Among Healthcare Providers in Côte d’Ivoire

C. Danel, M. Inghels, A. Desgrées du Loû, 2020, AIDS and Behavior.

Progression to WHO criteria for antiretroviral therapy in a 7-year cohort of adult HIV-1 seroconverters in Abidjan, Côte d'Ivoire.

R. Salamon, F. Dabis, A. Minga, 2007, Bulletin of the World Health Organization.

Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability

M. Weinstein, S. Resch, K. Freedberg, 2012, Cost Effectiveness and Resource Allocation.

HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, Côte d'Ivoire: A 4-year survey, 2002-2006.

R. Salamon, B. Masquelier, F. Dabis, 2007, AIDS research and human retroviruses.

Elite and viremic HIV-1 controllers in West Africa

C. Rouzioux, O. Lambotte, S. Eholie, 2021, AIDS.

What Level of Risk Compensation Would Offset the Preventive Effect of Early Antiretroviral Therapy? Simulations From the TEMPRANO Trial.

F. Lert, M. Boily, S. Eholie, 2016, American journal of epidemiology.

Association of Plasma sVCAM-1 and sCD14 with Mortality in HIV-1 Infected West African Adults with High CD4 Counts

C. Rouzioux, S. Eholie, C. Dunyach-Rémy, 2020, SSRN Electronic Journal.

Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis

R. Walensky, M. Huang, K. Freedberg, 2019, PloS one.

WHO guidelines for antiretroviral therapy in serodiscordant couples in sub-Saharan Africa: how many fit?

S. Eholie, X. Anglaret, C. Danel, 2014, AIDS.

Psychosocial correlates of inconsistent condom use among HIV‐infected patients enrolled in a structured ART interruptions trial in Côte d’Ivoire: results from the TRIVACAN trial (ANRS 1269)

M. Carrieri, C. Protopopescu, B. Spire, 2010, Tropical medicine & international health : TM & IH.

Medium-term probability of success of antiretroviral treatment after early warning signs of treatment failure in West African adults.

R. Salamon, E. Bissagnéné, S. Eholie, 2009, AIDS research and human retroviruses.

Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults.

S. Eholie, E. Messou, C. Seyler, 2008, Bulletin of the World Health Organization.

Early anthropometric and immunological success of antiretroviral therapy do not predict virological success in West African adults

Souleymane, S. Eholie, E. Messou, 2010 .

Identifying patients infected with hepatitis B virus in sub-Saharan Africa: potential for misclassification.

C. Delaugerre, F. Zoulim, S. Eholie, 2015, Diagnostic microbiology and infectious disease.

Telephone peer recruitment and interviewing during a respondent-driven sampling (RDS) survey: feasibility and field experience from the first phone-based RDS survey among men who have sex with men in Côte d’Ivoire

C. Danel, M. Inghels, A. Desgrées du Loû, 2021, BMC Medical Research Methodology.

Early ART Initiation in West Africa has no Adverse Social Consequences: A 24-Month Prospective Study

S. Eholie, X. Anglaret, C. Danel, 2016 .

Early antiretroviral therapy initiation in west Africa has no adverse social consequences: a 24-month prospective study

F. Lert, S. Eholie, X. Anglaret, 2016, AIDS.

Primary HIV-1 infection in African children infected through breastfeeding

F. Dabis, C. Rouzioux, N. Elenga, 2002, AIDS.

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

R. Salamon, H. Ahiboh, C. Rouzioux, 2015, The New England journal of medicine.

[Primary isoniazid preventive therapy : A strategy still relevant in the era of test and treat ; literature review].

X. Anglaret, T. Ouassa, C. Danel, 2022, Revue d'epidemiologie et de sante publique.

Lack of indinavir-associated nephrological complications in HIV-infected adults (predominantly women) with high indinavir plasma concentration in Abidjan, Côte d'Ivoire.

R. Salamon, G. Peytavin, E. Bissagnéné, 2007, AIDS research and human retroviruses.

High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial.

D. Ekouevi, S. Eholie, X. Anglaret, 2016, AIDS research and therapy.